Divalproex Sodium
Product Images NDC 68788-8085

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-8085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)

Chemical structure of divalproex sodium, illustrating two valproate molecules and one sodium ion in the compound's polymeric form.*

FDA Label Image

Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)

A cumulative percentage response curve graph showing percent reduction in CPS rate on the vertical axis and percent of patients on the horizontal axis. Two lines compare Divalproex Sodium Delayed-Release and placebo, illustrating the percent of patients experiencing various levels of CPS rate change from worsening to improvement.*

FDA Label Image

Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)

A line chart depicting the percentage reduction in CPS rate for high dose and low dose Divalproex Sodium Delayed Release. The x-axis shows the percentage of patients from 100% to 0%, and the y-axis shows the percentage reduction in CPS rate from -100% worsening to 100% improvement, illustrating patient response distribution to the treatments.*

FDA Label Image

Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)

A bar graph comparing two groups: Placebo and Divalproex Sodium Extended-Release Tablets. The vertical axis shows numerical values from 0.0 to 1.2. The bar for Placebo is labeled 0.6, while the bar for Divalproex Sodium Extended-Release Tablets is taller, at 1.2, with an asterisk indicating statistical significance (p=0.006).*

FDA Label Image

Divalproex Sodium Er Tab 500mg (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 06)

Label for Divalproex Sodium ER Tab 500mg, a generic of Depakote ER by Preferred Pharmaceuticals, Inc. The label includes directions in English and Spanish, space for dosage details, and a warning about storage temperature. Manufacturer information cites Lupin Pharmaceuticals, Inc. The label is predominantly white with a bright yellow section for directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.